Is It Safe to Stop Taking Wegovy, and What Should You Expect?

Step 1: Understand what stopping actually means for your body

Semaglutide does not vanish the moment you take your last pen. Its half-life means it clears gradually over roughly five to seven weeks, so the effects (both the appetite suppression and any side effects you were managing) wind down rather than cut off sharply. For most people this is reassuring: there is no abrupt rebound, no acute withdrawal, and no physical dependence in the pharmacological sense. What does come back, progressively, is your baseline appetite. The gastrointestinal effects of Wegovy that some people find hard to manage (nausea, digestive discomfort) tend to ease as the medicine clears, often noticeably within a week or two of the final dose.

Clinical trial follow-up data, published in the New England Journal of Medicine, showed that participants who stopped semaglutide after 68 weeks regained roughly two-thirds of the weight they had lost within a year. That is not a reason to avoid stopping when stopping is right, it is simply a fact worth building a plan around. Talk to your prescriber before the final dose if you can, so you are not navigating the transition alone.

Step 2: Recognise the situations where stopping promptly is the right call

There are circumstances where continuing Wegovy is not appropriate, and stopping quickly is the safer choice. Pregnancy is the clearest: Wegovy is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. The question of how long treatment should continue is also shaped by individual response, if you have not lost at least five percent of your starting weight after six months on the full maintenance dose, your prescriber will review whether continuing makes sense, in line with NICE guidance on semaglutide.

Planned surgery is another prompt to raise with your clinical team: anaesthetists need to know you are taking a GLP-1 medicine because gastric emptying is slowed, which has implications for fasting before a procedure. A new diagnosis, a significant change in other medicines, or a side effect that feels serious are all reasons to contact your prescriber rather than simply stopping unilaterally. Stopping is almost always safe, but stopping without anyone knowing, and without a plan, is where things can go wrong.

One practical habit: before your next pen arrives, take thirty seconds to check the patient information leaflet that came with your current pen. It lists the circumstances where you should contact a healthcare professional promptly, in plain language. It takes less than a minute, and it is there precisely for moments like this.

Step 3: Know when to get medical help, during or after stopping

Most people stop Wegovy without any dramatic side effects in either direction. Occasionally, something warrants urgent attention. Severe, persistent stomach pain that spreads towards the back, with or without vomiting, should be treated seriously, the MHRA's 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as an infrequent but potentially serious risk, and the guidance is to seek urgent medical care for pain fitting that description, whether you are mid-treatment or in the weeks following your last dose. You can report any suspected side effect (including ones that appear after stopping) through the MHRA's Yellow Card scheme, which helps regulators track patterns across the population.

Signs of dehydration after severe vomiting or diarrhoea, symptoms suggesting an allergic reaction, or a meaningful change in mood or thoughts of self-harm all warrant prompt contact with your GP or, if severe, emergency services. The NHS medicines page for semaglutide sets out these warning signs clearly and is a reliable first reference. If you have any doubt about what you are experiencing, contacting a healthcare professional is always the right move. Our aftercare team is available seven days a week for patients who have questions during or after treatment.

Step 4: Plan the transition, not just the stopping

Stopping Wegovy is a moment, but what comes after takes longer to navigate. The evidence is clear that the biological drivers of weight (appetite hormones, metabolic set-points) do not permanently change after a course of treatment ends, which is why the lifestyle habits built during treatment matter so much once the medicine is no longer doing part of the work. This is not a lecture on willpower. It is a reflection of how the biology actually works, and it is why the broader question of whether taking Wegovy is safe includes not just tolerability during treatment but what support looks like afterwards, a topic covered in more detail on our page looking at whether Wegovy is safe for different people and circumstances.

If you are thinking about stopping because of side effects, cost, or uncertainty about whether to continue, those are exactly the conversations our prescribers have with patients. Talking it through before stopping means you have a plan, whether that is a managed taper, a switch to an alternative, or a supported transition off the medicine. A consultation is free, and there is no pressure toward any particular outcome. Our clinical team reviews every patient's situation individually; if stopping is the right answer for you, they will say so. You can also read more about what side effects to expect when stopping Wegovy or explore the weight-loss treatment options that might suit your situation going forward. To speak with a prescriber, start your free consultation at any point.